Jane Street’s Nuvation Bio NUVB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-530,077
Closed -$2.95M 12557
2025
Q4
$4.75M Sell
530,077
-1,792,156
-77% -$11.1M ﹤0.01% 3310
2025
Q3
$8.59M Buy
+2,322,233
New +$6.33M ﹤0.01% 2613
2024
Q4
Sell
-84,039
Closed -$192K 10193
2024
Q3
$192K Sell
84,039
-213,290
-72% -$650K ﹤0.01% 8668
2024
Q2
$868K Buy
297,329
+183,676
+162% +$560K ﹤0.01% 6038
2024
Q1
$414K Sell
113,653
-59,898
-35% -$115K ﹤0.01% 7027
2023
Q4
$262K Buy
173,551
+163,537
+1,633% +$210K ﹤0.01% 7824
2023
Q3
$13.4K Sell
10,014
-24,177
-71% -$40.2K ﹤0.01% 8352
2023
Q2
$61.5K Sell
34,191
-221,430
-87% -$376K ﹤0.01% 8168
2023
Q1
$424K Buy
255,621
+97,602
+62% +$198K ﹤0.01% 6593
2022
Q4
$303K Buy
158,019
+837
+0.5% +$1.69K ﹤0.01% 7000
2022
Q3
$352K Sell
157,182
-35,399
-18% -$101K ﹤0.01% 7326
2022
Q2
$624K Buy
192,581
+168,219
+690% +$734K ﹤0.01% 6338
2022
Q1
$128K Buy
24,362
+3,070
+14% +$17.2K ﹤0.01% 9327
2021
Q4
$181K Buy
21,292
+642
+3% +$5.9K ﹤0.01% 8886
2021
Q3
$205K Buy
20,650
+7,677
+59% +$69.6K ﹤0.01% 8800
2021
Q2
$121K Sell
12,973
-3,865
-23% -$44.1K ﹤0.01% 9171
2021
Q1
$176K Buy
+16,838
New +$188K ﹤0.01% 8355

Other funds holding NUVB

Jane Street's NUVB Position: Q1 2026 in Review

Jane Street sold out of Nuvation Bio (NUVB) in Q1 2026, closing a stake of 530,077 shares — an estimated $2.95M sold.

Jane Street first reported a position in NUVB in Q1 2021 and held it in 17 quarters. The position peaked at $8.59M in Q3 2025. 233 funds tracked by Wall St. Rank hold NUVB as of Q1 2026.

  • Jane Street reported no remaining Nuvation Bio position as of Q1 2026 after selling out during the quarter.
  • Jane Street sold 530,077 Nuvation Bio shares in Q1 2026, an estimated $2.95M.
  • Jane Street first reported a position in Nuvation Bio in Q1 2021 and held it in 17 quarters.
  • Jane Street's Nuvation Bio position peaked at $8.59M in Q3 2025.
  • 233 funds tracked by Wall St. Rank held Nuvation Bio as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.